204 related articles for article (PubMed ID: 24639435)
21. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases.
Lamb H; Christie J; Singleton AB; Leake A; Perry RH; Ince PG; McKeith IG; Melton LM; Edwardson JA; Morris CM
Neurology; 1998 Feb; 50(2):388-91. PubMed ID: 9484359
[TBL] [Abstract][Full Text] [Related]
22. BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.
Lane R; He Y; Morris C; Leverenz JB; Emre M; Ballard C
Mov Disord; 2009 Feb; 24(3):392-400. PubMed ID: 19006190
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample.
Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Mullan M; Duara R
Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's disease.
Chen J; Shu H; Wang Z; Liu D; Shi Y; Xu L; Zhang Z
Oncotarget; 2016 Sep; 7(37):58789-58801. PubMed ID: 27542235
[TBL] [Abstract][Full Text] [Related]
25. APOE DNA methylation is altered in Lewy body dementia.
Tulloch J; Leong L; Chen S; Keene CD; Millard SP; Shutes-David A; Lopez OL; Kofler J; Kaye JA; Woltjer R; Nelson PT; Neltner JH; Jicha GA; Galasko D; Masliah E; Leverenz JB; Yu CE; Tsuang D
Alzheimers Dement; 2018 Jul; 14(7):889-894. PubMed ID: 29544979
[TBL] [Abstract][Full Text] [Related]
26. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
27. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
28. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E gene in physiological and pathological aging.
Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B
Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061
[TBL] [Abstract][Full Text] [Related]
30. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.
Engelborghs S; Dermaut B; Mariën P; Symons A; Vloeberghs E; Maertens K; Somers N; Goeman J; Rademakers R; Van den Broeck M; Pickut B; Cruts M; Van Broeckhoven C; De Deyn PP
Neurobiol Aging; 2006 Feb; 27(2):285-92. PubMed ID: 16399213
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
[TBL] [Abstract][Full Text] [Related]
32. APOE2: protective mechanism and therapeutic implications for Alzheimer's disease.
Li Z; Shue F; Zhao N; Shinohara M; Bu G
Mol Neurodegener; 2020 Nov; 15(1):63. PubMed ID: 33148290
[TBL] [Abstract][Full Text] [Related]
33. Involvement of ApoE4 in dementia with Lewy bodies in the prodromal and demented stages: evaluation of the Strasbourg cohort.
Bousiges O; Cretin B; Muller C; Botzung A; Sanna L; Anthony P; Philippi N; Demuynck C; Blanc F
Geroscience; 2024 Apr; 46(2):1527-1542. PubMed ID: 37653269
[TBL] [Abstract][Full Text] [Related]
34. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
[TBL] [Abstract][Full Text] [Related]
35. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
[TBL] [Abstract][Full Text] [Related]
36. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.
Kaivola K; Shah Z; Chia R; ; Scholz SW
Brain; 2022 Jun; 145(5):1757-1762. PubMed ID: 35381062
[TBL] [Abstract][Full Text] [Related]
37. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
Shea YF; Ha J; Chu LW
Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
[TBL] [Abstract][Full Text] [Related]
38. The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals.
Salvadó G; Ferreira D; Operto G; Cumplido-Mayoral I; Arenaza-Urquijo EM; Cacciaglia R; Falcon C; Vilor-Tejedor N; Minguillon C; Groot C; van der Flier WM; Barkhof F; Scheltens P; Ossenkoppele R; Kern S; Zettergren A; Skoog I; Hort J; Stomrud E; van Westen D; Hansson O; Molinuevo JL; Wahlund LO; Westman E; Gispert JD;
Alzheimers Dement; 2022 Jul; 18(7):1383-1395. PubMed ID: 34877786
[TBL] [Abstract][Full Text] [Related]
39. The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population.
Li Z; Yang N; Lei X; Lin C; Li N; Jiang X; Wei X; Xu B
J Clin Lab Anal; 2019 Sep; 33(7):e22950. PubMed ID: 31199015
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide analysis identified abundant genetic modulators of contributions of the apolipoprotein E alleles to Alzheimer's disease risk.
Nazarian A; Loika Y; He L; Culminskaya I; Kulminski AM
Alzheimers Dement; 2022 Nov; 18(11):2067-2078. PubMed ID: 34978151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
